ID

18974

Description

Positron Emission Tomography in Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00121212

Link

https://clinicaltrials.gov/show/NCT00121212

Keywords

Versions (1)
  1. 11/27/16 11/27/16 -
Uploaded on

November 27, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00121212

English

Eligibility Prostate Cancer NCT00121212

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed prostate cancer
Description

Prostate carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0600139
has completed conventional staging examinations, including biopsy with gleason score, ct scan of the abdomen and pelvis, and whole-body bone scintigraphy and conventional staging examinations negative
Description

Examination With staging conventional Complete | Biopsy Associated with Gleason score | CT of abdomen | Computed Tomography (CT) of Pelvis | Bone scintigraphy Whole body | Examination With staging conventional Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0031809
UMLS CUI [1,2]
C0332305
UMLS CUI [1,3]
C0439858
UMLS CUI [1,4]
C0205197
UMLS CUI [2,1]
C0005558
UMLS CUI [2,2]
C0332281
UMLS CUI [2,3]
C3203027
UMLS CUI [3]
C0412620
UMLS CUI [4]
C0412628
UMLS CUI [5,1]
C3889015
UMLS CUI [5,2]
C0444584
UMLS CUI [6,1]
C0031809
UMLS CUI [6,2]
C0332305
UMLS CUI [6,3]
C0439858
UMLS CUI [6,4]
C1513916
candidate for curative radical prostatectomy or curative radiotherapy or staging lymphadenectomy prior to surgery
Description

Indication Radical prostatectomy Curative | Indication Therapeutic radiology procedure Curative | Indication staging lymphadenectomy Before Operative Surgical Procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0194810
UMLS CUI [1,3]
C1276305
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C1276305
UMLS CUI [3,1]
C3146298
UMLS CUI [3,2]
C2019791
UMLS CUI [3,3]
C0332152
UMLS CUI [3,4]
C0543467
deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
Description

curative treatment Initial | Recurrence Intermediate Risk | Recurrence High risk

Data type

boolean

Alias
UMLS CUI [1,1]
C1273390
UMLS CUI [1,2]
C0205265
UMLS CUI [2,1]
C2825055
UMLS CUI [2,2]
C3640764
UMLS CUI [3,1]
C2825055
UMLS CUI [3,2]
C0332167
gleason score 7 and prostate-specific antigen (psa) 10-20 ng/ml
Description

Gleason score | Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C3203027
UMLS CUI [2]
C0201544
gleason score ≥ 8 and psa < 10 ng/ml
Description

Gleason score | Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C3203027
UMLS CUI [2]
C0201544
gleason score ≥ 8 and psa > 10 ng/ml
Description

Gleason score | Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C3203027
UMLS CUI [2]
C0201544
any gleason score and psa > 20 ng/ml
Description

Gleason score | Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C3203027
UMLS CUI [2]
C0201544
exclusion therapy:
Description

Exclusion Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0087111
not a candidate for treatment by surgery or radiation therapy with curative intent
Description

Indication Operative Surgical Procedures | Indication Therapeutic radiology procedure Curative intent

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0543467
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C1276305
inability to give informed consent
Description

Informed Consent Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years
Description

invasive cancer | Skin carcinoma | Malignant Neoplasms Evidence of

Data type

boolean

Alias
UMLS CUI [1]
C0677898
UMLS CUI [2]
C0699893
UMLS CUI [3,1]
C0006826
UMLS CUI [3,2]
C0332120
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00121212

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma
Item
newly diagnosed prostate cancer
boolean
C0600139 (UMLS CUI [1])
Examination With staging conventional Complete | Biopsy Associated with Gleason score | CT of abdomen | Computed Tomography (CT) of Pelvis | Bone scintigraphy Whole body | Examination With staging conventional Negative
Item
has completed conventional staging examinations, including biopsy with gleason score, ct scan of the abdomen and pelvis, and whole-body bone scintigraphy and conventional staging examinations negative
boolean
C0031809 (UMLS CUI [1,1])
C0332305 (UMLS CUI [1,2])
C0439858 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0005558 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C3203027 (UMLS CUI [2,3])
C0412620 (UMLS CUI [3])
C0412628 (UMLS CUI [4])
C3889015 (UMLS CUI [5,1])
C0444584 (UMLS CUI [5,2])
C0031809 (UMLS CUI [6,1])
C0332305 (UMLS CUI [6,2])
C0439858 (UMLS CUI [6,3])
C1513916 (UMLS CUI [6,4])
Indication Radical prostatectomy Curative | Indication Therapeutic radiology procedure Curative | Indication staging lymphadenectomy Before Operative Surgical Procedure
Item
candidate for curative radical prostatectomy or curative radiotherapy or staging lymphadenectomy prior to surgery
boolean
C3146298 (UMLS CUI [1,1])
C0194810 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C3146298 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
C3146298 (UMLS CUI [3,1])
C2019791 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
C0543467 (UMLS CUI [3,4])
curative treatment Initial | Recurrence Intermediate Risk | Recurrence High risk
Item
deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
boolean
C1273390 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C2825055 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
C2825055 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
Gleason score | Prostate specific antigen measurement
Item
gleason score 7 and prostate-specific antigen (psa) 10-20 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
gleason score ≥ 8 and psa < 10 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
gleason score ≥ 8 and psa > 10 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Gleason score | Prostate specific antigen measurement
Item
any gleason score and psa > 20 ng/ml
boolean
C3203027 (UMLS CUI [1])
C0201544 (UMLS CUI [2])
Exclusion Therapeutic procedure
Item
exclusion therapy:
boolean
C2828389 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Indication Operative Surgical Procedures | Indication Therapeutic radiology procedure Curative intent
Item
not a candidate for treatment by surgery or radiation therapy with curative intent
boolean
C3146298 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
Informed Consent Unable
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
invasive cancer | Skin carcinoma | Malignant Neoplasms Evidence of
Item
patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years
boolean
C0677898 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0006826 (UMLS CUI [3,1])
C0332120 (UMLS CUI [3,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial